Stoke Therapeutics Eulerpool Ziņas

Stoke Therapeutics Eulerpool News

Stoke Therapeutics Akciju Ziņas

Stoke Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Stoke Therapeutics ziņas mēs apkopojam šeit.

• 23. septembris ·

  GuruFocus
  Skorpios Trust Reduces Stake in Stoke Therapeutics Inc
• 13. septembris ·

  GuruFocus
  Redmile Group, LLC Expands Stake in Atara Biotherapeutics Inc
• 10. septembris ·

  Yahoo
  Stoke Therapeutics Presents Zorevunersen Data Showing Substantial Reductions in Seizures and Improvements in Multiple Measures of Cognition and Behavior That Support the Potential for Disease Modification in Dravet Syndrome
• 10. septembris ·

  Thefly.com
  Stoke Therapeutics presents Zorevunersen data at EEC
• 7. septembris ·

  SeekingAlpha
  Stoke Therapeutics: The First Gene Therapy For Dravet Syndrome
• 4. septembris ·

  Yahoo
  Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer
• 4. septembris ·

  Thefly.com
  Stoke Therapeutics appoints Eric Olson Chief Business Officer.
• 3. septembris ·

  Yahoo
  Stoke Therapeutics to Present at Upcoming Investor Conferences in September
• 16. augusts ·

  Yahoo
  Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
• 9. augusts ·

  Stock Options Channel
  Commit To Purchase Stoke Therapeutics At $12.50, Earn 27.6% Annualized Using Options